Taiwan · Delayed Price · Currency is TWD EirGenix Statistics
Total Valuation
EirGenix has a market cap or net worth of TWD 21.14 billion. The enterprise value is 19.29 billion.
| Market Cap | 21.14B |
| Enterprise Value | 19.29B |
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EirGenix has 302.37 million shares outstanding. The number of shares has decreased by -0.43% in one year.
| Current Share Class | 302.37M |
| Shares Outstanding | 302.37M |
| Shares Change (YoY) | -0.43% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 1.42% |
| Owned by Institutions (%) | 7.34% |
| Float | 192.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.12 |
| PB Ratio | 2.50 |
| P/TBV Ratio | 2.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.40 |
| EV / Sales | 20.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.31 |
Financial Position
The company has a current ratio of 6.86, with a Debt / Equity ratio of 0.15.
| Current Ratio | 6.86 |
| Quick Ratio | 5.46 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.76 |
| Interest Coverage | -114.19 |
Financial Efficiency
Return on equity (ROE) is -9.93% and return on invested capital (ROIC) is -5.02%.
| Return on Equity (ROE) | -9.93% |
| Return on Assets (ROA) | -4.78% |
| Return on Invested Capital (ROIC) | -5.02% |
| Return on Capital Employed (ROCE) | -8.36% |
| Revenue Per Employee | 955,398 |
| Profits Per Employee | -901,569 |
| Employee Count | 207 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 1.28 |
Taxes
In the past 12 months, EirGenix has paid 1.76 million in taxes.
| Income Tax | 1.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.51% in the last 52 weeks. The beta is 0.45, so EirGenix's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -31.51% |
| 50-Day Moving Average | 62.57 |
| 200-Day Moving Average | 68.22 |
| Relative Strength Index (RSI) | 76.60 |
| Average Volume (20 Days) | 1,093,532 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EirGenix had revenue of TWD 955.40 million and -901.57 million in losses. Loss per share was -2.96.
| Revenue | 955.40M |
| Gross Profit | 214.44M |
| Operating Income | -814.94M |
| Pretax Income | -899.81M |
| Net Income | -901.57M |
| EBITDA | -576.96M |
| EBIT | -814.94M |
| Loss Per Share | -2.96 |
Balance Sheet
The company has 3.14 billion in cash and 1.30 billion in debt, giving a net cash position of 1.84 billion or 6.09 per share.
| Cash & Cash Equivalents | 3.14B |
| Total Debt | 1.30B |
| Net Cash | 1.84B |
| Net Cash Per Share | 6.09 |
| Equity (Book Value) | 8.46B |
| Book Value Per Share | 27.98 |
| Working Capital | 3.85B |
Cash Flow
In the last 12 months, operating cash flow was -412.22 million and capital expenditures -1.29 billion, giving a free cash flow of -1.71 billion.
| Operating Cash Flow | -412.22M |
| Capital Expenditures | -1.29B |
| Free Cash Flow | -1.71B |
| FCF Per Share | -5.64 |
Margins
Gross margin is 22.44%, with operating and profit margins of -85.30% and -94.37%.
| Gross Margin | 22.44% |
| Operating Margin | -85.30% |
| Pretax Margin | -94.18% |
| Profit Margin | -94.37% |
| EBITDA Margin | -60.39% |
| EBIT Margin | -85.30% |
| FCF Margin | n/a |
Dividends & Yields
EirGenix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -4.27% |
| FCF Yield | -8.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EirGenix has an Altman Z-Score of 7.6 and a Piotroski F-Score of 1.
| Altman Z-Score | 7.6 |
| Piotroski F-Score | 1 |